Results 191 to 200 of about 83,464 (331)

Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.
AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland, Richard FitzGerald, Elizabeth Challenger, Laura Dickinson, Laura J. Else, Lauren Walker, Colin Hale, Victoria Shaw, Callum Kelly, Rebecca Lyon, Jennifer Gibney, Karim Dhamani, Margaret Irwin, Yvanne Enever, Michelle Tetlow, William Wood, Helen Reynolds, Justin Chiong, Orod Osanlou, Henry Pertinez, Katie Bullock, William Greenhalf, Andrew Owen, David G. Lalloo, Michael Jacobs, Julian A. Hiscox, Thomas Jaki, Pavel Mozgunov, Geoffrey Saunders, Gareth Griffiths, Saye H. Khoo, Thomas E. Fletcher, on behalf of the AGILE CST‐6 Study Group, Shazaad Ahmad, Christopher J. Edwards, Lesley Dry, Georgie McKenzie, Aleksandra Ros, Michael Stackpoole, Laura Bradley, Karen Jennings‐Wilding, Nicholas Paton, Fred Hayden, Janet Darbyshire, Amy Lucas, Ulrika Lorch, Andrew Freedman, Richard Knight, Steven Julious   +48 more
wiley   +1 more source

Viral Hemorrhagic Fever [PDF]

, 2020
openaire   +3 more sources

Update on viral hemorrhagic fevers

International Journal of Infectious Diseases, 2014
R. Swanepoel
doaj   +1 more source

Emerging Infection of Sudan Ebola Virus: Implications and India's Role. [PDF]

Indian J Community Med
Kumar D, Rana RK.
europepmc   +1 more source

Viral hemorrhagic fevers (continued) (Week 47) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents week ending November 26, 2022

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Exploring the Nutraceutical Potential of Achillea millefolium L.: Phytochemical Composition, Biological Activities, and Industrial Applications

Food Science &Nutrition, Volume 14, Issue 6, June 2026.
Achillea millefolium Linn., commonly known as yarrow, is an extraordinary medicinal plant. A. millefolium has broad therapeutic potential due to its phytochemistry and essential oil composition. It possesses pharmacological properties, including antidiabetic, antioxidant, anti‐inflammatory, liver‐protective, antimicrobial, and gastroprotective effects,
Tooba Majeed, Muhammad Tauseef Sultan, Ahmad Mujtaba Noman, Hassan Raza, Hagar M. Mohamed, Nimra Anees, Muhammad Imran, Muzzamal Hussain, Gamal A. Mohamed, Sabrin R. M. Ibrahim, Entessar Al Jbawi, Ehab M. Mostafa, Samy Selim, Ayman Salama, Mohamed A. Abdelgawad   +14 more
wiley   +1 more source

Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo Virus. [PDF]

Pathogens
Johnson DM, Jan S, Dunn E, Comer JE, Cross RW, Geisbert TW.   +5 more
europepmc   +1 more source

Viral hemorrhagic fevers (continued) (Week 42) Weekly cases of notifiable diseases United States U.S. territories and Non-U.S. Residents week ending October 22, 2022

This data includes weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents, specifically covering Viral hemorrhagic fevers cases.

core  

Dengue fever in Iran: An emerging threat requiring urgent public health interventions

New Microbes and New Infections
Hassan Karami, Mostafa Salehi-Vaziri
doaj   +1 more source

Ethiopia's first Marburg virus outbreak - Implications for emerging hemorrhagic fevers in Africa. [PDF]

New Microbes New Infect
Al-Tawfiq JA.
europepmc   +1 more source